LDL-C Reduction
TK NEXLIZET Prescribing Information NEXLETOL Prescribing Information For your patients who require additional support in managing their low-density lipoprotein cholesterol (LDL-C) levels, nonstatin therapies like NEXLIZET® (bempedoic acid/ezetimibe) and NEXLETOL® (bempedoic […]
Primary Prevention and Secondary Prevention
TK NEXLIZET Prescribing Information NEXLETOL Prescribing Information As a healthcare provider treating statin-intolerant patients, you may find that the CLEAR Outcomes trial provides data to help shape your clinical decisions. The […]
Payer Coverage
NEXLIZET Prescribing Information NEXLETOL Prescribing Information Access to NEXLIZET® or NEXLETOL® is easier than ever. With expanded access through major payers—Medicare/government, UnitedHealthcare, Cigna, Aetna, and more—patients have the potential to benefit from these options. Explore the information below to discover how you can help improve access for your patients by staying updated on the latest […]
Additional Data Analyses
LDL-C Reduction Data
Samples
Financial Support
Patient Support
Access (PDF)
